GlassScriptPhysician profile
Naresh K Ahuja
NPI 1013174598
$17,184.17
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,518 · 2020: $3,205 · 2021: $4,285 · 2022: $212 · 2023: $764 · 2024: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558 · Travel and Lodging: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.85 |
| Travel and Lodging | $406.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,687.19 | 2019-2023 | |
| Medtronic, INC. | $1,639.01 | 2021-2024 | Ligasure, Signia, Bravo |
| Davol INC. | $818.06 | 2019-2024 | Phasix Mesh |
| Boston Scientific Corporation | $791.16 | 2019 | |
| Covidien LP | $94.88 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.89 | 2024 | Trintellix |
| Laborie Medical Technologies Corp. | $24.39 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Janssen Pharmaceuticals, INC | $23.97 | 2024 | Spravato |
| Baxter Healthcare | $23.67 | 2023 | Floseal |
| Abbvie INC. | $16.44 | 2021 | |
| Novo Nordisk INC | $15.44 | 2024 | |
| Rhythm Pharmaceuticals, INC. | $15.07 | 2024 | Imcivree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naresh Ahuja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.